Rubicon Research (RUBICON) Q4 25/26 earnings summary

Executive summary

• Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved, with an unmodified audit opinion from Deloitte Haskins & Sells LLP.

• A final dividend of ₹1.50 per equity share was recommended for FY26, subject to shareholder approval at the AGM.

• The company completed a successful IPO in October 2025, raising ₹13,775 million, with shares listed on NSE and BSE.

Financial highlights

• Consolidated revenue from operations for FY26 was ₹17,539.56 million, up from ₹12,842.72 million in FY25.

• Net profit after tax for FY26 was ₹2,467.35 million, compared to ₹1,343.61 million in FY25.

• Standalone revenue for FY26 was ₹13,060.82 million, up from ₹10,738.43 million in FY25.

• Standalone net profit after tax for FY26 was ₹1,881.65 million, up from ₹1,675.37 million in FY25.

• Basic EPS (consolidated) for FY26 was ₹15.52, up from ₹8.82 in FY25.

Outlook and guidance

• The company is focused on deploying unutilized IPO proceeds for debt repayment and strategic acquisitions.

• A definitive agreement was signed to acquire 85% of Arinna Lifesciences Limited for ₹1,759.17 million, completed in April 2026.